Precision BioSciences
precisionbiosciences.com · Technology · DTIL
Ranked 986 of 2,047 companies in the study
- Visibility7
- Citations0
- Sentiment88
- Site quality67
- AI readiness29
AI assistants name Precision BioSciences in 6.7% of answers, less often than the typical company in the technology sector. Its overall score is 33 out of 100, ranking 986th of 2,047 companies. The website passes 4 out of 14 technical checks for AI tool readiness.
We asked 15 unbranded questions about the technology market: none named Precision BioSciences. AI assistants named it in 4 of 60 answers (6.7%). The typical technology company is named in 10.0% of answers. By how often it is named, Precision BioSciences ranks 165 of 273 in its sector.
Every dot is a company in the study. Hover one to see it; click to open its report.
This companySame sectorEvery other companyNever named
Five parts, each scored out of 100.
How often AI assistants name the company
How often AI uses the company's own website as a source
How positively AI describes the company
How well built the website's own pages are
How easily AI tools can read and use the website
Visibility is calculated from the answers on this page. How the score is built.
273 companies in this sector. The line on each bar is the typical company.
An answer that names the company
“Is investing in genome editing technologies for HBV worthwhile for clinical development?”
Investing in genome editing technologies for Hepatitis B virus (HBV) clinical development appears to be a worthwhile endeavor, driven by the significant unmet need for a cure for chronic HBV infection and promising early clinical trial results.
Current treatments for chronic HBV can suppress the virus but rarely eliminate it due to the persistence of covalently closed circular DNA (cccDNA) and integrated HBV DNA in host cells, which act as viral reservoirs. Genome editing technologies, such as CRISPR/Cas9, offer a potential solution by directly targeting and disrupting these viral DNA forms, …
The AI’s answer as we received it, shortened and not checked for accuracy.
How the mentions in these answers were split between this company and its rivals
Answers naming it, out of answers received
What this website publishes for an AI agent to read, use and buy from, on a scale of six levels.
- 0
- 1
- 2
- 3
- 4
- 5
Level 1: Basic web presence. Two of robots.txt, a sitemap and Link headers are in place.
- Content Signals
Show every check, for your technical teamHide the checks
- study: 92.0%robots.txtPassed
A valid robots.txt with crawl rules at the site root.
- study: 86.8%SitemapPassed
An XML sitemap listing the pages, ideally referenced from robots.txt.
- study: 0.3%Link headersNot met
Send Link headers such as rel="api-catalog" or rel="describedby" on the homepage.
- study: 5.5%DNS for AI DiscoveryNot present
Advertise agent endpoints with SVCB records under _agents.
- study: 1.9%Markdown negotiationNot met
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
- study: 25.1%llms.txtNot met
Publish an llms.txt with a short summary and the key links.
- study: 93.4%AI bot rulesPartly met
Add explicit robots.txt groups for the main AI crawlers.
- study: 1.4%Content SignalsNot met
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
- study: 0.2%Web Bot AuthNot present
Only relevant if you run your own agents or crawlers: publish a signing key directory.
- study: 0.3%API CatalogNot met
List public APIs in a linkset at /.well-known/api-catalog.
- study: 11.8%OAuth discoveryNot met
Publish OpenID Connect or OAuth server metadata under /.well-known.
- study: 10.3%OAuth Protected ResourceNot met
Serve protected resource metadata at /.well-known/oauth-protected-resource.
- study: 0.0%auth.mdNot met
Publish an auth.md describing how agents sign in.
- study: 0.2%MCP Server CardNot met
Offer an MCP server and publish its server card under /.well-known.
- study: 0.1%A2A Agent CardNot met
Publish an agent card at /.well-known/agent-card.json.
- study: 0.2%Agent SkillsNot met
Publish a skills index with the main tasks agents can do.
- study: 33.7%WebMCPCould not check
Register key actions such as search or cart as WebMCP tools.
- study: 0.1%ARD manifestNot met
Publish an ai-catalog.json listing every agent interface.
Score 25 of 100 · 97% of checks could run · checked on October 5, 2026 · precisionbiosciences.com · 2,047 companies scanned
4 of 14 passed. This list is for your technical team. The percentage is how many companies in the study pass each check.
These 14 checks ran during the audit and are what the AI readiness part of the overall score counts. The scan above ran later and is stricter on Link headers and Markdown, so a check can pass here and not there.
Show the 14 checksHide them
- Passedrobots.txt publishedstudy: 85.0%
- PassedXML sitemapstudy: 73.2%
- PassedHTTP Link headers (RFC 8288)study: 29.0%
- Not metMarkdown content negotiationstudy: 8.3%
- Not metllms.txt publishedstudy: 21.7%
- PassedToken budget (page weight)study: 95.2%
- Not metExplicit AI bot rulesstudy: 13.0%
- Not metAPI Catalog (.well-known/api-catalog)study: 0.2%
- Not metOAuth Authorization Server discoverystudy: 10.1%
- Not metOAuth Protected Resource discoverystudy: 9.3%
- Not metMCP Server Cardstudy: 0.0%
- Not metA2A Agent Cardstudy: 0.0%
- Not metWebMCP toolsstudy: 4.2%
- Not metAgent Skills declaredstudy: 0.0%
This website sets no rules for any AI crawler by name, like 84% of the websites whose rules we could read. Every AI crawler follows its general rules.
- GPTBotallowed
- ClaudeBotallowed
- Anthropic-AIallowed
- Google-Extendedallowed
- Applebot-Extendedallowed
- Meta-ExternalAgentallowed
- FacebookBotallowed
- Bytespiderallowed
- CCBotallowed
- Diffbotallowed
- Omgilibotallowed
- OAI-SearchBotallowed
- Claude-SearchBotallowed
- PerplexityBotallowed
- Applebotallowed
- Amazonbotallowed
- YouBotallowed
- ChatGPT-Userallowed
- Claude-Userallowed
- Perplexity-Userallowed
- DuckAssistBotallowed
- MistralAI-Userallowed
Read from the website’s own rules file (robots.txt). An asterisk marks a crawler the file names. The rest follow its general rules. “Partly” means only some pages are blocked.
How many times each website was listed as a source in these answers
In the study as US-listed.
- What factors influence the cost of genome editing therapies in the United States?
- Nuclease-based genome editing vs base editing: which is more effective for DMD therapy?
- What are the leading genome editing platforms currently used for treating genetic diseases?
- Is investing in genome editing technologies for HBV worthwhile for clinical development?
- How does genome editing differ from traditional gene therapy for rare diseases?
- How is genome editing used to target and eliminate hepatitis B infections?
- Average investment required for clinical-stage research using genome editing technologies?
- Are newer gene editing approaches for DMD likely to outperform older therapeutic strategies?
- Which technologies compete with genome editing for addressing chronic viral infections?
- What are the main research applications of genome editing in Duchenne muscular dystrophy?
- Best genome editing methods for targeting hepatitis B virus in clinical research?
- What are common challenges faced when deploying genome editing platforms in clinical trials?
- Emerging trends in genome editing for patient-centric rare disease therapies?
- Why might a genome editing trial for a genetic disorder fail to show clinical benefit?
- What are the main alternatives to genome editing for treating inherited diseases?
Columns, left to right: OpenAI, Claude, Perplexity, Gemini. The AI assistants often disagree. Across the study, on 40% of the questions where a company is named, only one of the four names it.
A badge of this result that you can show on your own website. Copy the code below.
<a href="https://aeo-audit.rezolve.com/us/precisionbiosciences.com"><img src="https://aeo-audit.rezolve.com/us/badges/precisionbiosciences.com.svg" alt="Overall score 33 of 100, US AI Visibility Study 2026" width="280" height="64"></a>